Encompass Health (EHC) will report quarterly earnings on Tuesday

Encompass Health (NYSE:EHC – Get Rating ) will post its quarterly earnings data after the market closes on Tuesday, February 7th. Analysts expect the company to post earnings of $0.85 per share for the quarter. Parties interested in listening to the company’s conference call may do so using this link.

Encompass Health Trading down 0.7%

EHC opened at $60.94 on Tuesday. Encompass Health has a one year low of $44.33 and a one year high of $74.61. The stock has a market cap of $6.08 billion, a PE ratio of 22.40, a P/E/G ratio of 2.59 and a beta of 1.02. The business’s 50-day moving average is $59.11 and its 200-day moving average is $53.81. The company has a debt-to-equity ratio of 1.59, a quick earnings ratio of 1.21, and a current ratio of 1.21.

Wall Street analysts forecast growth

A number of analysts have issued reports on EHC shares. TheStreet upgraded Encompass Health from a “c+” rating to a “b-” rating in a research report on Wednesday, December 21st. StockNews.com began coverage on Encompass Health in a research report on Wednesday, October 12th. They issued a “hold” rating on the stock. Stephens reduced their target price on Encompass Health from $60.00 to $58.00 and set an “overweight” rating on the stock in a research report on Friday, October 28th. Finally, Raymond James boosted their target price on Encompass Health from $65.00 to $72.00 and gave the company a “strong-buy” rating in a research report on Friday, October 28th. One research analyst has rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $64.13, according to MarketBeat.

Institutional Trading of Encompass Health

A number of large investors have recently modified their holdings of EHC. US Bancorp DE boosted its holdings in Encompass Health by 66.4% in the first quarter. US Bancorp DE now owns 9,336 shares of the company’s stock valued at $664,000 after purchasing an additional 3,725 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new position in Encompass Health during the first quarter valued at $318,000. PNC Financial Services Group Inc. boosted its holdings in Encompass Health by 10.5% in the first quarter. PNC Financial Services Group Inc. now owns 8,750 shares of the company’s stock valued at $622,000 after purchasing an additional 834 shares in the last quarter. Bank of Montreal Can boosted its holdings in Encompass Health by 1.5% in the first quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock valued at $806,000 after purchasing an additional 173 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Encompass Health by 10.5% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 36,463 shares of the company’s stock valued at $2,593,000 after buying an additional 3,477 shares during the last quarter. Hedge funds and other institutional investors own 96.14% of the company’s shares.

About Encompass Health

(Get Rating)

Encompass Health Corp. is committed to providing post-acute health care services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitation treatment and care for patients recovering from stroke and other neurological conditions, heart and lung disease, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Selected articles

This instant news alert is generated by narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reporting. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Encompass Health, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients daily. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now, before the broader market takes a nosedive … and Encompass Health wasn’t on the list.

Although Encompass Health currently has a “Buy” rating among analysts, the top-rated analysts think these five stocks are better buys.

Check out the five stocks here